Literature DB >> 12960332

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.

William E Biddison1, Richard V Turner, Susan J Gagnon, Avital Lev, Cyril J Cohen, Yoram Reiter.   

Abstract

Both TCRs and Ab molecules are capable of MHC-restricted recognition of peptide/MHC complexes. However, such MHC restriction is the predominant mode of recognition by T cells, but is extremely rare for B cells. The present study asks whether the dichotomy in Ag recognition modes of T and B cells could be due to fundamental differences in the methods by which TCRs and Abs recognize peptide/MHC complexes. We have compared MHC and peptide recognition by panels of CTL lines specific for the Tax and M1 peptides presented by HLA-A2 plus Tax and M1 peptide/HLA-A2-specific human Fabs that were selected from a naive phage display library. Collectively, the results indicate both striking similarities and important differences between Fab and TCR recognition of MHC and peptide components of the Tax and M1/HLA-A2 complexes. These findings suggest that these two classes of immunoreceptors have solved the problem of specific recognition of peptide/MHC complexes by nonidentical mechanisms. This conclusion is important in part because it indicates that Ab engineering approaches could produce second-generation Ab molecules that more closely mimic TCR fine specificity. Such efforts may produce more efficacious diagnostic and therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960332     DOI: 10.4049/jimmunol.171.6.3064

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.

Authors:  Oleg Y Borbulevych; Tiffany K Baxter; Zhiya Yu; Nicholas P Restifo; Brian M Baker
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.

Authors:  Christopher J Holland; Rory M Crean; Johanne M Pentier; Ben de Wet; Angharad Lloyd; Velupillai Srikannathasan; Nikolai Lissin; Katy A Lloyd; Thomas H Blicher; Paul J Conroy; Miriam Hock; Robert J Pengelly; Thomas E Spinner; Brian Cameron; Elizabeth A Potter; Anitha Jeyanthan; Peter E Molloy; Malkit Sami; Milos Aleksic; Nathaniel Liddy; Ross A Robinson; Stephen Harper; Marco Lepore; Chris R Pudney; Marc W van der Kamp; Pierre J Rizkallah; Bent K Jakobsen; Annelise Vuidepot; David K Cole
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

3.  TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.

Authors:  Mahiuddin Ahmed; Andres Lopez-Albaitero; Dmitry Pankov; Brian H Santich; Hong Liu; Su Yan; Jingyi Xiang; Pei Wang; Aisha N Hasan; Annamalai Selvakumar; Richard J O'Reilly; Cheng Liu; Nai-Kong V Cheung
Journal:  JCI Insight       Date:  2018-02-22

4.  Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?

Authors:  Nadia Anikeeva; Tatiana Mareeva; Wei Liu; Yuri Sykulev
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

5.  A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

Authors:  Sojung Kim; Amelia K Pinto; Nancy B Myers; Oriana Hawkins; Krysten Doll; Saghar Kaabinejadian; Jason Netland; Michael J Bevan; Jon A Weidanz; William H Hildebrand; Michael S Diamond; Ted H Hansen
Journal:  Eur J Immunol       Date:  2014-05-03       Impact factor: 5.532

6.  Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.

Authors:  Junyun Lai; Wei Jian Tan; Chien Tei Too; Joanna Ai Ling Choo; Lan Hiong Wong; Fatimah Bte Mustafa; Nalini Srinivasan; Angeline Pei Chiew Lim; Youjia Zhong; Nicholas R J Gascoigne; Brendon J Hanson; Soh Ha Chan; Jianzhu Chen; Paul A MacAry
Journal:  Blood       Date:  2016-06-23       Impact factor: 22.113

7.  Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.

Authors:  Steven M Truscott; Xiaoli Wang; Lonnie Lybarger; William E Biddison; Cortez McBerry; John M Martinko; Janet M Connolly; Gerald P Linette; Daved H Fremont; Ted H Hansen; Beatriz M Carreno
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

8.  Examining variable domain orientations in antigen receptors gives insight into TCR-like antibody design.

Authors:  James Dunbar; Bernhard Knapp; Angelika Fuchs; Jiye Shi; Charlotte M Deane
Journal:  PLoS Comput Biol       Date:  2014-09-18       Impact factor: 4.475

9.  Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexes.

Authors:  Jianrong L Low; Anneta Naidoo; Gladys Yeo; Adam J Gehring; Zi Zong Ho; Yin Hoe Yau; Susana G Shochat; David M Kranz; Antonio Bertoletti; Gijsbert M Grotenbreg
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  A novel composite immunotoxin that suppresses rabies virus production by the infected cells.

Authors:  Tatiana Mareeva; Celestine Wanjalla; Matthias J Schnell; Yuri Sykulev
Journal:  J Immunol Methods       Date:  2009-11-22       Impact factor: 2.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.